I think the biggest challenges arise from a lack of oversight. A 2017 study published in JAMA suggests only about 30% of CBD products are labeled correctly. The

I think the biggest challenges arise from a lack of oversight. A 2017 study published in JAMA suggests only about 30% of CBD products are labeled correctly. The failing products either had inaccurate CBD concentrations or contained things they shouldn't, like THC in a THC-free products or mycotoxins from poor quality control. The FDA has said they are trying to fast track regulations for hemp and CBD, but it has been much too slow for the industry. Once there are clear (and hopefully sane) rules and regulations, I think you will see a drop off in the number of companies and a rise in the quality of products. We also need to work on getting the price down for consumers.